The SUNY Poly alumni-led spinoff, Glauconix Biosciences, a specialty pharma research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development, was featured in "SUNY Tech Forward," a newsletter which focused on student startups.

In particular, Glauconix recently announced that the company had been awarded an NSF phase IIB Small Business Innovation Research Grant. The award is expected to support further expansion of Glauconix's business into efforts related to the posterior segment of the eye.

To view the SUNY Tech Forward Newsletter, please visit here.

To read the full Glauconix Biosciences news release, visit here.